Increased risk for CNS relapse in pre-B cell leukemia with the t(1;19)/TCF3-PBX1..     ///    "These data suggest that with contemporary treatment, patients with the t(1;19) and TCF3/PBX1 fusion have a favorable overall outcome but increased risk of CNS relapse.. "